Reference 2020-296

REF:            2020-296

Subject:        Treatment of Atopic Dermatitis




I am conducting some research into the treatment of Atopic Dermatitis in the UK, and how this compares with other countries in Europe.  I would really appreciate if you could answer two questions.

First, could you tell me how many Atopic Dermatitis patients have been treated by your trust in the latest four months that you have data available for, and how many of these patients were paediatric versus adult?

Second, for all Atopic Dermatitis patients (adult plus paediatric) treated by your trust in the latest four months, could you please provide the number of patients treated with each of the following:

High Potency topical steroids, Ultraviolet light, therapy, Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mefetil, Acitretin, Alitretinoin, Dupilumab, Upadacitinib, Tacrolimus, Pimecrolimus.



We do not record this information because our Community Services are not clinically coded.